![](./img/Group_55.png)
![](img/home-aboutus.png)
About US
Kannavis iTrade: Value Chain Specialist’s connecting the industry from Hemp Biomass to Medical Cannabis.
![](./img/plant.png)
![](./img/sales.png)
Canada cannabis sales rises to 4 billion, 25 billion in USA, 2 billion in Germany in 2022. Cannabis is now the 6th most valuable crop in USA.
![](./img/networking.png)
There is a global over supply of inferior mass-produced cannabis. Greater demand now than ever for craft cannabis from small batch producers.
![](./img/connection.png)
Disconnect from producers to end clients. We vet out all groups and pivot them in supply chain to help bottom-line and achieve profitability sooner.
Trends & Growth
26.6 Billion | Hemp biomass (only CBD) projected sales by 2025 CAGR of 34% |
82 Billion | Medical Cannabis alone projected sales by 2027 CAGR of 20.25% |
146 Billion | Recreational and medical cannabis projected sales by 2025 |
![](./img/Graph_00141.jpg)
Trends & Growth
26.6 Billion | Hemp biomass (only CBD) projected sales by 2025 CAGR of 34% |
82 Billion | Medical Cannabis alone projected sales by 2027 CAGR of 20.25% |
146 Billion | Recreational and medical cannabis projected sales by 2025 |
Our Solutions
![](img/transaction.jpg)
Kannavis iTrade
0% compensation as you're advisor
• Strategic advisor
• Restoration cultivation group
• Consultant, business advisor
• Finance group.
• Offering offtake agreements.
• Restoration cultivation group
• Consultant, business advisor
• Finance group.
• Offering offtake agreements.
![](img/002.jpg)
Kannavis iREC
Recreational Cannabis
• Our groups review licensed producers to ensure they are 100% craft for rec market.
• Our group reviews end distribution points to ensure a seamless supply chain.
• We advise, offer, and present curated stabilized genetics for the rec market.
• Our group can offer small batches to controlled dried flower on weekly basis.
• Our group reviews end distribution points to ensure a seamless supply chain.
• We advise, offer, and present curated stabilized genetics for the rec market.
• Our group can offer small batches to controlled dried flower on weekly basis.
![](img/Medical-Marijuana.jpg)
Kannavis iMed
Medical Cannabis
• We curate small batches of craft flower for CUMCS and EU-GMP markets.
• We offer education to physicians, genetics, controlled cultivation, and offtake agreements.
• Our group still grows for medical patients in Canada under ACMPR personal access program.
• We align physicians, nursery, cultivation team, and constant feedback loop holistic care.
• We work alongside established medical supply clinics with minimum 5 years of service NOT in cannabis industry. Separating "cannabis influencing clinic" from Health and wellness clinics.
• We are the alternative to pharmaceutical care.
• We base our practice on a holistic approach, rather than prescribing on symptoms only.
• We offer education to physicians, genetics, controlled cultivation, and offtake agreements.
• Our group still grows for medical patients in Canada under ACMPR personal access program.
• We align physicians, nursery, cultivation team, and constant feedback loop holistic care.
• We work alongside established medical supply clinics with minimum 5 years of service NOT in cannabis industry. Separating "cannabis influencing clinic" from Health and wellness clinics.
• We are the alternative to pharmaceutical care.
• We base our practice on a holistic approach, rather than prescribing on symptoms only.
![kannabis-map](./img/group_456.png)
location
Canada
Location T.O.
Available Area 1500 m 2
Our company's head office is located in Toronto, Canada.
![](./img/plants.png)